Hims vs OlleveCare
Hims and OlleveCare sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
OlleveCare
Best for: a published list of the 13 states it serves, when most sellers publish none
Visit OlleveCare →If you are choosing between Hims and OlleveCare, price alone will not settle it. Hims leads our six-part score, 6.8 to 3.9. One of the two has an FDA warning letter on record, covered below.
Hims vs OlleveCare price
Hims publishes $199 a month. OlleveCare does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; OlleveCare does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while OlleveCare posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and OlleveCare lists 13 states.
They overlap in 12 states. Hims alone covers 38 states, including Alaska, Alabama, Arkansas and California. OlleveCare alone covers District of Columbia.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
OlleveCare
Pricing not publicly listed.
What each price covers
Hims' price also covers the medication itself, which OlleveCare does not claim.
Hims is silent on shipping and lab work.
OlleveCare does not say what its price includes.
That matters most for the drug: unless OlleveCare confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
OlleveCare
Inclusions not disclosed.
Where each one scores higher
Overall, Hims scores 6.8 and OlleveCare 3.9 out of 10.
Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 2.5), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 4.1).
OlleveCare is stronger on support (5.0 vs 3.0).
Value is within half a point.
Hims
6.8/10
OlleveCare
3.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
OlleveCare has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | OlleveCare |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓6 features |
| States Available | ✓50 | 13 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About OlleveCare
Booking has to begin before a price appears, and OlleveCare says nothing about its operating entity, its medical director or the pharmacy behind it. The storefront is small and started in virtual urgent care, adding a cash-pay weight-management track on compounded semaglutide and compounded tirzepatide; 13 states are listed, DC among them. Urgent care by video and refills of non-controlled drugs remain part of what it does.
Read our full OlleveCare review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
OlleveCare
What we like
- We found no FDA warning letters issued to OlleveCare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Serves only 13 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 3.9, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. OlleveCare fits better if a published list of the 13 states it serves, when most sellers publish none is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose OlleveCare if…
You want a published list of the 13 states it serves, when most sellers publish none.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Hims vs OlleveCare: FAQ
Close alternatives to Hims and OlleveCare
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- OlleveCare vs Embody
- OlleveCare vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.